Kennedy At HHS Health Reform

🖨️ Print post

Play Audio

Kennedy at HHS: Reform, Resistance And The Battle Over America’s Health

Since the start of President Trump’s second term, few appointments have stirred as much optimism—or controversy—as that of Robert F. Kennedy, Jr. as Secretary of Health and Hu­man Services (HHS). To his supporters, it felt like a long-awaited reckoning: a fierce critic of the health establishment stepping inside the very system he had spent years exposing. To his detractors, it was a perilous experiment, placing a skeptic of federal health orthodoxy in charge of the agencies he had so often accused of corruption and deceit.

From the outset, Kennedy made no secret of his mission. He hadn’t come to tinker with a broken system; he intended to break it open. His promises—transparency, accountability and a realignment of public health priorities with the people’s trust—resonated deeply with mil­lions who had lost faith in the very institutions charged with protecting them.

Yet as 2025 draws to a close, we must ask the question: how much has truly changed? Inside Washington, resistance and sabotage run deep. For decades, interests both hidden and overt have steadily built up an infrastructure to poison—and, as we saw during Covid, kill—the American people; those entities and the corporate alliances that have facilitated the poisoning will be hard to unwind.

Within the health freedom movement, opinions are divided. Some believe Kennedy is moving at lightning speed, while others suggest he is playing a long game, working from within to loosen the machinery he seeks to transform. Some are restless, yearning for clearer proof that the poisoning infrastructure is being dismantled. For many of us who have been involved in this movement for years, the moment feels both promis­ing and fraught. The tension between patience and urgency is unmistak­able. Remaking a system this vast is unlikely to be quick work—but for families whose lives have been shaped by the systemic corruption, every delay feels achingly personal. As Kennedy approaches one year in office, let’s take a look at what has transpired in 2025.

THE CONFIRMATION FIRESTORM

From the moment his nomination was announced, Kennedy faced an unrelenting barrage of attacks. In late January 2025, he appeared before the Senate Finance Committee and the Health, Education, Labor and Pensions (HELP) Committee for his confirmation hearings.^1,2 Senators questioned whether his views about issues like vaccination and regulatory capture could align with the existing culture of federal health leadership. The tone was sharp from the outset—more trial than dialogue—foreshad­owing months of political and media hostility to come.

By May, Kennedy was back before Congress for his first central budget and oversight hearings. During the Senate HELP Committee’s review of the FY2026 HHS budget, he outlined an ambitious plan to restructure the agency, pledging to cut waste, redirect funds toward preventive health and expand independent research.³ Before an Ap­propriations subcommittee, he defended new funding priorities at the National Institutes of Health (NIH).⁴ Meanwhile, in the House Energy and Commerce Health Subcommittee, mem­bers grilled him on scientific integrity and his sweeping personnel changes.⁵ Together, these hearings created a public record that his critics weaponized to paint him as reckless, ideological and unfit for the role of HHS Secretary.

The Senate Finance Committee’s review of the administration’s 2026 health agenda on September 4 marked a low point for civility.⁶ The session quickly devolved into open hostility, with senators seizing the opportunity to attack Kennedy’s overhaul of entrenched leadership, his redistribution of authority within the Cen­ters for Disease Control and Prevention (CDC) and his insistence on greater vaccine oversight. The hearing stood out for its sheer antagonism; committee members repeatedly interrupted Kennedy and denied him the courtesy of being able to complete his responses, seeming less in­terested in hearing Kennedy’s testimony than in performing outrage for the cameras. What could have been a civil exchange of ideas became a spectacle and public inquisition.

COORDINATED ATTACKS

For decades, federal health policy has been shaped by a tight-knit circle of insiders—agency officials, corporate lobbyists and grant-depen­dent academics—who attend the same confer­ences, speak the same institutional language and quietly safeguard one another’s interests. Kennedy arrived at HHS with the potential to disrupt that ecosystem and reengineer health governance to serve the public rather than pow­erful corporate patrons. His critics understand the stakes: even partial success could mean exposure of the long-standing alliance between regulators and industry.

Not surprisingly, that threat mobilized a well-coordinated backlash—what Sayer Ji (founder of GreenMedInfo and chairman of the Global Wellness Forum) describes as an orchestrated, multi-front campaign to discredit Kennedy. Seven concurrent petitions—orga­nized by emergent front groups such as Stand Up for Science, Physicians for a Healthy De­mocracy and the scientific advisory board of a journalism institute—have reportedly gathered over one hundred thousand signatures demand­ing Kennedy’s removal.⁷ Open letters dated August 20 and September 3, launched through a “Save HHS” campaign, garnered thousands of signatures from current and former HHS employees.^8,9 Around the same time, a coalition of medical organizations announced a march on Washington, echoing the call for Kennedy’s dismissal.^10,11

Beyond partisan opposition in Congress and predictable condemnation from the legacy press, Kennedy has also faced rebuke from six former U.S. surgeons general—Jerome Adams, Richard Carmona, Joycelyn Elders, Vivek Murthy, Antonia Novello and David Satcher—who co-authored a joint op-ed claim­ing that his leadership “endangers the health of the nation.”¹² The statement underscored the deep institutional hostility and resistance to Kennedy’s stated agenda.

On September 12, Senator Bernie Sanders published an op-ed in Britain’s The Guardian,¹³ mocking Kennedy’s appointment and calling for his resignation. In concert, media outlets and allied lawmakers amplified the message, casting Kennedy as “anti-science.” Ji’s documentation shows the reinforcement of these narratives through selective leaks, synchronized talking points and congressional theatrics designed to erode public confidence.¹⁴ Leaked minutes from an April 2025 meeting of the Biotechnol­ogy Innovation Organization’s (BIO’s) Vaccine Policy Steering Committee reveal that industry lobbyists committed two million dollars to pres­sure Congress against Kennedy’s agenda.^10,15 According to those minutes (page 3, section 5a), the committee urged members to “go to The Hill and lobby that it is time for RFK Jr. to go.”¹⁵

In October 2024, prior to Kennedy taking office, Ji had already reported on internal docu­ments from the UK-based Center for Counter­ing Digital Hate (CCDH) outlining proposed “black-ops” media strategies aimed at Kennedy and his allies.¹⁴ According to Ji, a Freedom of Information Act (FOIA) release showed overlap between CCDH’s network and Western intel­ligence, including the UK’s National Security Unit and cooperative arrangements across mul­tiple countries.¹⁶ [Editor’s note: On November 13, The Defender reported that the U.S. may deport CCDH’s CEO for its targeting of public figures, including Kennedy, for statements about vaccines.¹⁷]

INITIAL ACCOMPLISHMENTS

From his first days, Kennedy made clear that his HHS leadership would not be sym­bolic, taking immediate steps toward structural and leadership changes, advisory committee replacements, grant reallocations and policy resets. Within hours of his swearing in, for ex­ample, he launched the Make America Healthy Again (MAHA) initiative—an executive-level commission tasked with investigating the root causes of chronic childhood disease, overhaul­ing nutrition and preventive health policies and lessening the institutional inertia that has toler­ated widespread poisoning.¹⁸

Also almost immediately, Kennedy ordered sweeping internal audits—an unprecedented move requiring agencies under the HHS um­brella to disclose conflicts of interest, funding relationships and communications between regulators and pharmaceutical executives. The message was unmistakable: transparency was no longer optional.^19,20 Next, Kennedy ap­proved a major departmental reorganization that reduced the HHS workforce by roughly ten thousand positions, consolidated overlapping divisions and established a new entity—the Administration for a Healthy America—under the MAHA umbrella.²¹ The restructuring alters how the Food and Drug Administration (FDA), CDC, NIH and other HHS branches operate on a daily basis and embeds the MAHA framework across HHS’s core functions.

Kennedy also influenced leadership ap­pointments at the highest levels of federal health oversight. The Senate confirmed his picks of Dr. Martin “Marty” Makary as FDA Commissioner and Dr. Jay Bhattacharya as NIH Director—two medical insiders who have strategically cultivated a reputation as being reform-minded and patient-centered. The most optimistic observers viewed their confirmations as signaling a modest shift in federal priorities away from pharmaceutical influence and toward scientific independence.^22,23 Others were more skeptical.

In June 2025, in perhaps his most consequential policy decision, Kennedy reconstituted the CDC’s Advisory Committee on Immunization Practices (ACIP),²⁴ replacing the existing membership in a move framed as necessary to “restore public trust in vaccine decision-making.”²⁵ Soon after, he oversaw major leadership changes at the CDC, including remov­ing several senior officials and agency director Dr. Susan Monarez in August 2025.²⁶ During a Senate hearing the following month, Monarez faced intense scrutiny over the CDC’s continued endorsement of Covid-19 shots for children and healthy adults, despite data pointing to elevated rates of myocarditis²⁷ (620 percent) among young men who received the shots. Monarez was unable to explain why approximately seven hundred eighty-two thousand “vaccine” injury reports from the CDC’s V-Safe system had not been released to the public.²⁸ The exchange became a flashpoint in national coverage of Kennedy’s actions.

Kennedy also directed new research investments under MAHA. In May 2025, the MAHA Commission released a report on the rise of childhood chronic disease, exploring connections between diet, chemical exposure and environmental risk.²⁹ That same month, Kennedy unveiled the fifty million dollar NIH-funded Autism Data Science Initiative.³⁰ Ken­nedy argued that federal research dollars should no longer be dominated by entrenched biomedical interests and called for a shift aligned with the MAHA philosophy focused on prevention, nutrition and environmental risk factors.³¹ Kennedy also proposed adding autism-related symptoms to the National Vaccine Injury Compensation Program—acknowledging families long ignored by federal health authorities.³²

WHAT THE NEW ACIP HAS—AND HASN’T—DONE

ACIP is the body responsible for developing vaccine recommenda­tions in the United States. Composed of medical experts, researchers and public health officials, ACIP’s guidance shapes the national vaccination schedule and directly influences which vaccines are recommended for both children and adults. Once the CDC director formally endorses the ACIP recommendations, they become official policy—affecting millions of Americans and the broader public health landscape.³³

With Kennedy at the helm of HHS, the new ACIP has undertaken broader discussions than in the past, but no substantive policy shifts have resulted from those discussions. For example, following Kennedy’s an­nouncement in May that the CDC would no longer universally recommend Covid shots for healthy children (but would still perversely recommend them for immunocompromised children),³⁴ ACIP at its mid-September meeting reclassified Covid-19 shots for both children and adults as “shared clinical decision-making” products.³⁵ That designation essentially made explicit what should have already gone without saying, namely that decisions about whether to accept the shots are up to the individuals or parents concerned, with input from their health care providers.³⁶ In May, Kennedy also asserted that CDC would no longer recommend the shots for healthy pregnant women, but for months afterwards, the agency’s webpage titled “About Vaccines and Pregnancy” continued to state that “COVID-19 vaccines are not harmful for pregnant women and their babies.” As of October 22, 2025, that webpage stated that its content was being updated “to align with recently revised ACIP vaccine rec­ommendations.”³⁷

In September, reports circulated that Michi­gan Congresswoman Haley Stevens was draft­ing articles to impeach Kennedy, citing “health care chaos,” “reckless cuts” and the modified Covid-19 shot recommendations.³⁸ However, constitutional restrictions make impeach­ment unlikely—particularly in a Republican-controlled Congress. Public records show that Stevens receives campaign contributions from health care professionals and major pharmaceu­tical and medical industry interests,³⁹ raising questions about conflicts of interest.

A second September decision by ACIP involved discontinuing the combined MMRV (measles-mumps-rubella-varicella) vaccine for children under age four,⁴⁰ due to a higher risk of febrile seizures in young MMRV recipients compared with children receiving separate MMR and varicella shots.⁴¹ This move was a nod to evidence known to—but largely ignored by— regulators since 2008.⁴² ACIP members also discussed whether to recommend delaying the birth dose of hepatitis B (HepB) vaccine to one month, while some argued for a full reevaluation of universal infant HepB vaccination; however, they tabled the motion pending “more data.”

The mixed-message tone of the new ACIP was apparent a few months earlier at the committee’s first meeting in June,⁴³ when it expanded CDC’s recommendations related to respiratory syncytial virus (RSV), endorsing the new monoclonal antibody clesrovimab⁴⁴ (alongside the already-approved nirsevimab) for infants and broadening RSV vaccine cov­erage to adults aged fifty to seventy-four “at increased risk of severe RSV disease.”⁴⁵ At that June meeting, ACIP also reaffirmed the long-standing recommendation that everyone over six months of age receive an annual flu shot—while departing from precedent to affirm Kennedy’s call to eliminate the mercury-based preservative thimerosal from influenza vaccines administered to children, pregnant women and other adults.43 Kennedy remarked, “Injecting any amount of mercury into children when safe, mercury-free alternatives exist defies common sense and public health responsibility.”⁴⁶

For other long-standing vaccines—such as polio, DTaP (diphtheria-tetanus-acellular pertussis) and human papillomavirus (HPV)— little has changed. In June, ACIP quietly backed off from a vote to expand HPV vaccination to younger children. Thus far, it has left the broader childhood immunization schedule, which has nearly tripled since the 1990s, largely unexam­ined.⁴⁷ Nor has the ACIP workgroup examining vaccines during pregnancy recommended any substantial changes.

Kennedy’s reshuffling of ACIP has at least opened new avenues for scrutiny and debate. Overall, however, ACIP’s early actions reflect cautious and largely token recalibration rather than sweeping overhaul. Fundamental questions of safety, transparency and conflicts of interest remain unresolved.

AUTISM HEARINGS

On September 9, 2025—just days before ACIP convened—Senator Ron Johnson led a Senate Homeland Security and Governmental Affairs subcommittee hearing on vaccine safety, scientific corruption and transparency.⁴⁸ The session contrasted sharply with a September 4 hearing of the Senate Finance Committee, at which was present Senator Bill Cassidy, one of the figures identified in the leaked BIO reports as playing a role in the apparently politically motivated campaign against Kennedy.10 Com­menting on the hearing’s belligerent tone, Ala­bama Senator Tommy Tuberville spoke on the Senate floor in defense of Kennedy:

“Mr. President, what the American people saw last week in the Finance Committee with Health and Human Services Secretary Robert F. Kennedy Jr. was not a hearing on oversight. It was a dogpile by politicians who are scared to death of questioning the status quo. It was Washington at its worst—a full-on blitz against one man for the simple crime of telling the truth and refusing to play ball with the swamp.”⁴⁹

At Johnson’s hearing, which emphasized evidence and proceeded with a spirit of inquiry, attorney Aaron Siri, Esq.,⁵⁰ and researcher Toby Rogers, PhD,⁵¹ testified on the corruption of science and its influence on public perception and vaccine policy. Siri presented an unpublished 2020 study analyzing the health records of over eighteen thousand children, showing that vaccinated children experience chronic illness at rates two and a half times higher than their unvaccinated peers, including significantly more asthma, allergic disorders, autoimmune diseases and neurological conditions.⁵² Rogers highlighted the rise of autism, methodological flaws in mainstream research and the absence of vaccinated-versus-unvaccinated comparisons (whether government or pharmaceutical company-funded), citing a 2021 study by Brian Hooker and Neil Miller showing a fivefold increased autism risk associated with vaccination in certain contexts.⁵³

Although Johnson’s hearing generated optimism, we have only to look at historical precedent to temper our expectations. Similar hearings in the past—while exposing agency failures and raising awareness—have not produced meaningful change. In her analysis of the Johnson hearing, Peggy Hall of the Healthy American noted the delayed public release of the 2020 study discussed by Siri, pointedly asking why it was “tucked away for five years.”⁵⁴ Suggesting that various hearings held by Sena­tor Johnson may be serving a purpose of deflection, Hall raised several practical questions: “What products have been pulled off the market? What warnings have been given to Americans? And what justifications are being given that the government actually has a say in telling you that you should be injected anyway?”

The truth is, we don’t need more studies to prove vaccine harm— hundreds of peer-reviewed papers have already documented the risks. Kennedy and Brian Hooker’s book Vax-Unvax: Let the Science Speak highlights more than a hundred of these studies. On October 27, the Mc­Cullough Foundation published a report on the determinants of autism spectrum disorder (ASD) that concluded with the obvious: “Combination and early-timed routine childhood vaccination constitutes the most sig­nificant modifiable risk factor for ASD.”⁵⁵ Calling for additional research only delays accountability and leaves more children vulnerable.

AUTISM/TYLENOL PRESS CONFERENCE

On September 22, Kennedy, President Trump and Dr. Mehmet Oz held a press conference that captured national attention and shifted the conversation around autism.⁵⁶ For many parents and advocates, having high-level leaders publicly question long-held assumptions about what is “safe and effective” for their children and acknowledge concerns long dis­missed by mainstream medicine was a watershed moment. Kennedy said,

“For too long, families have been left without answers or options as autism rates have soared. Today, we are taking bold action— opening the door to the first FDA-recognized treatment pathway [leucovorin—a treatment for cerebral folate deficiency in children with autism-related symptoms], informing doctors and families about potential risks, and investing in groundbreaking research. We will follow the science, restore trust, and deliver hope to millions of American families.”

The press conference, which focused partic­ular attention on acetaminophen (Tylenol), was not without controversy. Some critics denounced the emphasis on prenatal acetaminophen use as unfairly blaming mothers, even though the concerns raised about the over-the-counter drug were grounded in science. Pediatricians often recommend acetaminophen to manage post-vac­cination fever or pain, and studies have linked prenatal or early-life acetaminophen exposure to neurodevelopmental changes, including increased risk of autism and attention-deficit/ hyperactivity disorder (ADHD).^57,58 Research also suggests that acetaminophen may interfere with masculinization,⁵⁹ reduce empathy and increase risk-taking behavior. Internal emails from Tylenol manufacturer Johnson & Johnson reveal that the company was aware of the po­tential risks long ago; FDA had even reviewed the concerns following a 2014 JAMA Pediatrics study.⁶⁰ On the same day as the press confer­ence, FDA announced that it would be updating acetaminophen labeling.⁶¹

Beyond the discussion of acetaminophen, President Trump introduced several additional and seemingly off-the-cuff bombshells into the conversation, suggesting that taking measles, mumps and rubella vaccines separately rather than in a combined MMR formulation might be preferable; commenting on the potential removal of aluminum from vaccines (“Who the hell wants that pumped into a body?”); and suggesting that “There’s no reason to give a baby that’s almost just born” the HepB vaccine.⁶²

“TRUMPRx”

One week after the autism press conference, President Trump took health policy in the op­posite direction, announcing the “TrumpRx” initiative: a partnership with Pfizer (and possibly other pharmaceutical companies) positioned as a program to lower drug costs. Critics immediate­ly pointed to the lack of disclosure—ironic given Kennedy’s emphasis on transparency—and the potentially lucrative profits that could accrue to the president through royalties or licensing fees tied to Trump’s name.^63,64 With numerous legal and ethical questions surrounding the TrumpRx deal, entities like Public Citizen are submitting FOIA requests to clarify the contracts, conflicts of interest and financial flows.⁶⁵

In announcing TrumpRx, the president also publicly praised Pfizer CEO Albert Bourla,⁶⁶ not mentioning either Bourla’s or his own role in Operation Warp Speed. For families whose loved ones were killed or disabled by Pfizer’s high-risk Covid shots, the Pfizer and Bourla en­dorsements felt untethered from accountability. “Pfizer rewarded, America backstabbed” is how epidemiologist Nicholas Hulscher put it, point­ing out that Pfizer, operating like a “criminal enterprise,” has incurred one hundred seven documented penalties—and over eleven billion dollars in fines—for fraud, false marketing and bribery.⁶⁷

As much as we may criticize pharmaceuti­cal industry excesses, the TrumpRx deal also reminds us that we must be cautious about replacing corporate control with government control. Do we really want to live in a world where the government becomes the nation’s pharmacist? At a time when we are facing the very real threats of centralized digital IDs and programmable money, the implications are chilling: “Have you taken your prescribed drug?” could one day determine whether you receive your universal basic income or maintain your social credit score. It’s a dangerous prec­edent—especially amid emerging discussions about embedding chips in medications.⁶⁸

As the Trump Administration’s and Ken­nedy’s “Rx” for reform increasingly veers to­ward AI-enabled wearables and other high-tech health tools,⁶⁹ it is essential to recognize the uses of “innovations” as a cover term for control. Catherine Austin Fitts has long warned about digital systems that offer “convenience” on the front end while quietly expanding surveillance, behavioral monitoring and financial leverage on the back end.⁷⁰ Kennedy himself once acknowledged that digital IDs can “make you a slave,”⁷¹ yet his HHS is spearheading the push for wearables—tracking devices—for tens of millions of Americans and is embracing AI-driven analysis of federal health-care data. Publicly, Kennedy frames this effort as “harnessing technology to deliver person­alized, real-time insights that empower better health decisions,” but the reality is that the players and the systems are little different from those about which he used to issue warnings. AI, data integration and biometric monitoring create the architecture for unprecedented centralization of power and control.

IT’S UP TO US

Kennedy’s leadership marks a turning point—a long-awaited crack in the machinery that has driven decades of unaccountable and harmful public health policy. For the first time in a generation, a national figure has been willing to confront the sacred cows of the medical-pharmaceu­tical-industrial complex. Kennedy deserves credit for his courage and discipline—reportedly working fourteen-hour days to unwind a deeply embedded system.

At the same time, the months of hearings and press conferences since Kennedy’s nomination and confirmation as HHS Secretary reveal not just the promise but also the peril of this new chapter in American health reform. On one hand, topics once dismissed as “controversial” or “conspiracy theory” have opened up at the highest levels of government. On the other hand, true leadership demands clarity. The health freedom movement cannot afford double-speak or gestures that lend legitimacy to the very system that has produced a poisoned population. When Ken­nedy agreed with Senator Cassidy that President Trump deserves a Nobel Prize for Operation Warp Speed,⁷² he undermined the experiences of those injured—a constituency that he proudly spoke on behalf of before taking office. When he announced that HHS is “winding down” mRNA vaccine development activities but will proceed full steam ahead with other “novel” vaccine platforms and “better solutions,”⁷³ his willingness to question the vaccine enterprise as a whole also came into question. Political pressure will always tempt even the most principled reformers to compromise— but truth requires consistency. The millions of families who have suffered and continue to suffer vaccine injury and other forms of medi­cal poisoning deserve unwavering honesty, not political calibration.

Kennedy has opened a door, but it is up to us to walk through it. No single man or woman, however devoted, can rescue us from the consequences of our own complacency. True reform begins when we, as individuals and communities, take responsibility for our own health—when we stop hoping someone else will fix the system and instead begin to live differently, think critically and refuse to comply with policies that violate conscience and common sense. Hope, untethered from ac­tion, becomes a kind of surrender. We wouldn’t pour the ingredients of a vaccine into a baby’s bottle—so why should we accede to government demands that we inject those ingredients into our children? The time for hoping is over. The time for sovereignty has begun.

REFERENCES

1. Hearing to consider the nomination of Robert F. Kennedy, Jr., of California, to be Secretary of Health and Human Services. Senate Committee on Finance, Jan. 29, 2025.
2. Nomination of Robert F. Kennedy, Jr. to serve as Secre­tary of Health and Human Services. Senate Committee on Health, Education, Labor & Pensions, Jan. 30, 2025.
3. Hearing on Fiscal Year 2026 Department of Health and Human Services Budget. Senate Committee on Health, Education, Labor & Pensions, May 14, 2025.
4. A Review of the President’s Fiscal Year 2026 Budget Re­quest for the Department of Health and Human Services. Senate Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, May 20, 2025.
5. Health Subcommittee Hearing: The Fiscal Year 2026 De­partment of Health and Human Services Budget. House Energy and Commerce Committee, Subcommittee on Health, June 24, 2025.
6. The President’s 2026 Health Care Agenda. Senate Commit­tee on Finance, Sep. 4, 2025.
7. Public health coalition to march to capitol and deliver over 100,000 petition signatures demanding removal of RFK Jr. Stand Up for Science, Oct. 20, 2025.
8. HHS staff response to the August 8th attack. Savehhs.org, Aug. 20, 2025.
9. It’s time for Robert F. Kennedy, Jr. to resign. Savehhs.org, Sep. 3, 2025.
10. Ji S. The coup: how big pharma’s $2 million war chest bought this Wednesday’s Senate hearing. Sayer Ji: Health, Truth, and Freedom [Substack], Sep. 14, 2025.
11. March for Health & Science. Washington, DC, Nov. 5, 2025. https://www.911forhealthandscience.org/
12. Nevradakis M. Ex-surgeons general latest to join RFK Jr. smear campaign. The Defender, Oct. 8, 2025.
13. Sanders B. RFK Jr does not just reject vaccines. He rejects science and must step down. The Guardian, Sep. 12, 2025.
14. Ji S. From “black ops” to Bernie’s byline: the documented foreign campaign against RFK Jr. Sayer Ji: Health, Truth, and Freedom [Substack], Sep. 13, 2025.
15. BIO Vaccine Policy Steering Committee (VPSC) meet­ing, Apr. 3, 2025. https://www.documentcloud.org/documents/25988188-vaccine-strategy-memo/
16. Ji S. Breaking: International governments are criminalizing free speech through global coordination; new files expose plot. GreenMedInfo, Oct. 16, 2024.
17. Nevradakis M. UK activist behind “disinformation dozen” faces possible U.S. deportation. The Defender, Nov. 13, 2025.
18. https://www.hhs.gov/maha/index.html
19. Manto M. RFK Jr.’s planned assault on corporate influence is clashing with reality. National Center for Health Research, Jun. 26, 2025.
20. Kennedy RF Jr., Haley V, Rollins B, et al. The MAHA Re­port. Make America Healthy Again Commission, May 2025. https://www.whitehouse.gov/wp-content/uploads/2025/05/WH-The-MAHA-Report-Assessment.pdf
21. Cirruzzo C, Cancryn A. “Painful period”: RFK Jr. elimi­nates 10,000 jobs at HHS. Politico, Mar. 27, 2025.
22. Martin A. Makary, M.D., M.P.H., sworn in as FDA Com­missioner. FDA, Apr. 1, 2025.
23. Jay Bhattacharya begins tenure as 18th Director of the National Institutes of Health. NIH, Apr. 1, 2025.
24. Burdick S. CDC’s new vaccine advisers vow to study cumu­lative effect of childhood vaccine schedule. The Defender, Jun. 25, 2025.
25. Terhune C. Kennedy’s ouster of US vaccine advisors puts pharma ties under scrutiny. Reuters, Jun. 12, 2025.
26. Aboulenein A, Levine D, Erman M. US CDC chief fired after weeks in role, challenges ouster as four top officials resign. Reuters, Aug. 28, 2025.
27. New study: mRNA vaccines trigger 620% heart risk surge in young men. Independent Medical Alliance [Substack], Apr. 14, 2025.
28. Greene J. New data is out on COVID vaccine injury claims. What’s to make of it? Reuters, Oct. 12, 2022.
29. MAHA Commission unveils sweeping strategy to Make Our Children Healthy Again. HHS, Sep. 9, 2025.
30. NIH launches $50M Autism Data Science Initiative to unlock causes and improve outcomes. NIH, Sep. 22, 2025.
31. Statement by Robert F. Kennedy, Jr., Secretary, U.S. Department of Health and Human Services on The Presi­dent’s Fiscal Year 2026 Budget before Committee on Ap­propriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies. U.S. House of Representatives, May 14, 2025. https://docs.house.gov/meetings/AP/AP07/20250514/118230/HHRG-119-AP07-Wstate-KennedyR-20250514.pdf
32. US health secretary Kennedy considers adding autism symptoms to vaccine injury program, Bloomberg News reports. Reuters, Sep. 25, 2025.
33. Advisory Committee on Immunization Practices. ACIP recommendations. CDC, Aug. 8, 2025. https://www.cdc.gov/acip/vaccine-recommendations/index.html
34. Baletti B. CDC updates childhood schedule with new COVID vaccine recommendation for kids, but advice for pregnant women still unchanged. The Defender, May 30, 2025.
35. Meeting of the Advisory Committee on Immunization Practices. Atlanta, GA: CDC, Sep. 18-19, 2025. https://www.youtube.com/watch?v=-6uBNXsYRHQMeeting of the Advisory Committee on Immunization Practices. Atlanta, GA: CDC, Sep. 18-19, 2025. https://www.youtube. com/watch?v=-6uBNXsYRHQ
36. ACIP recommends COVID-19 immunization based on individual decision-making. HHS, Sep. 19, 2025.
37. https://www.cdc.gov/vaccines-pregnancy/about/index.html
38. Nevradakis M. Impeach RFK Jr.? Critics pan congress­woman’s plan to launch impeachment bid. The Defender, Sep. 25, 2025.
39. https://www.opensecrets.org/members-of-congress/haley-stevens/summary?cid=N00040915
40. Moniuszko S. CDC’s vaccine advisory panel, with new members picked by RFK Jr., votes on measles shot. CBS News, Sep. 18, 2025.
41. https://www.fda.gov/media/147563/download
42. Klein NP, Fireman B, Yih WK, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics. 2010 Jul;126(1):e1–e8.
43. CDC’s Advisory Committee on Immunization concludes meeting with joint statement. CDC, Jun. 26, 2025.
44. Moulia DL, Link-Gelles R, Chu HY, et al. Use of cles­rovimab for prevention of severe respiratory syncytial virus-associated lower respiratory tract infections in infants: recommendations of the Advisory Committee on Immuni­zation Practices—United States, 2025. MMWR Morb Mortal Wkly Rep. 2025 Aug 28;74(32):508-514.
45. https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/adults.html
46. HHS adopts ACIP recommendation to remove thimerosal from all U.S. influenza vaccines. HHS, Jul. 23, 2025.
47. Next ACIP meeting: anticipated votes. CDC, Sep. 19, 2025.
48. How the corruption of science has impacted public percep­tion and policies regarding vaccines. Senate Committee on Homeland Security & Governmental Affairs, Subcommittee on Investigations, Sep. 9, 2025. https://www.hsgac.senate.gov/subcommittees/investigations/hearings/how-the-corruption-of-science-has-impacted-public-perception-and-policies-regarding-vaccines/
49. Tuberville defends Secretary Robert F. Kennedy Jr. fol­lowing deep state attacks. Coach Tommy Tuberville, U.S. Senator for Alabama, Sep. 9, 2025.
50. Siri A. [Letter from Aaron Siri, Esq. to Chairman Ron Johnson re hearing titled, How the Corruption of Science has Impacted Public Perception and Policie Regarding Vaccines.] Sep. 5, 2025. https://www.hsgac.senate.gov/wp-content/uploads/Siri-Testimony-1.pdf
51. Rogers T. [Written statement from Toby Rogers, PhD, MPP to Permanent Subcommittee on Investigations, Committee on Homeland Security and Governmental Affairs.] Sep. 9, 2025. https://www.hsgac.senate.gov/wp-content/uploads/Rogers-Testimony.pdf
52. Lamerato L, Chatfield A, Tang A, Zervos M. Impact of childhood vaccination on short and long-term chronic health outcomes in children: a birth cohort study. Henry Ford Health System, unpublished. https://www.hsgac.senate.gov/wp-content/uploads/Entered-into-hearing-record-Impact-of-Childhood-Vaccination-on-Short-and-Long-Term-Chronic-Health-Outcomes-in-Children-A-Birth-Cohort-Study.pdf
53. Hooker BS, Miller NZ. Health effects in vaccinated versus unvaccinated children, with covari­ates for breastfeeding status and type of birth. J Transl Sci. 2021;7:1-11. https://www.oatext.com/pdf/JTS-7-459.pdf
54. Hall P. Committee of Homeland Security hearing on VACCINES: the good, the bad and the ugly. The Healthy American, Peggy Hall [Substack], Sep. 10, 2025. https://peggyhall.substack.com/p/committee-of-homeland-security-hearing
55. Hulscher N, Leake JS, Troupe S, et al. McCullough Foundation report: determinants of autism spectrum disorder. Oct. 27, 2025. https://zenodo.org/records/17451259
56. President Trump, Secretary Kennedy announce bold actions to tackle autism epidemic. HHS, Sep. 22, 2025.
57. Ji Y, Azuine RE, Zhang Y, et al. Association of cord plasma biomarkers of in utero acet­aminophen exposure with risk of attention-deficit/hyperactivity disorder and autism spectrum disorder in childhood. JAMA Psychiatry. 2020 Feb 1;77(2):180-189.
58. Baletti B. Tylenol, FDA knew about autism risk for years, newly surfaced emails show. The Defender, Sep. 29, 2025.
59. Hay-Schmidt A, Finkielman OTE, Jensen BAH, et al. Prenatal exposure to paracetamol/ acetaminophen and precursor aniline impairs masculinisation of male brain and behaviour. Reproduction. 2017 Aug;154(2):145-152.
60. Liew Z, Ritz B, Rebordosa C, et al. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr. 2014 Apr;168(4):313-320.
61. FDA responds to evidence of possible association between autism and acetaminophen use during pregnancy. FDA, Sep. 22, 2025.
62. https://rollcall.com/factbase/trump/transcript/donald-trump-remarks-health-autism-white-house-september-22-2025/
63. Burdick S. Secrecy over Trump-Pfizer deal sparks FOIA demands and public outcry. The Defender, Oct. 1, 2025.
64. Latypova S. The art of the drug deal: Pfizer may funnel up to ~$500M to Trump organization via TrumpRx. Due Diligence and Art [Substack], Sep. 30, 2025.
65. Public Citizen FOIAs Pfizer-Trump deal text. Public Citizen, Oct. 1, 2025.
66. Watch: Trump announces deal with Pfizer to lower drug prices. WSJ News, Sep. 30, 2025. https://www.youtube.com/watch?v=vrxbd97Tfc8
67. Hulscher N. The MAHA betrayal: Pfizer rewarded, America backstabbed. Focal Points, Oct. 2, 2025. https://www.thefocalpoints.com/p/the-maha-betrayal-pfizer-rewarded
68. Huff E. Flashback: Pfizer CEO Albert Bourla fantasized at World Economic Forum in 2018 about feeding people Wi-Fi microchip drugs. Natural News, May 24, 2022.
69. Singh P. US Health Secretary Kennedy says HHS to launch campaign to encourage wearable devices. Investing.com, Jun. 24, 2025.
70. https://x.com/solari_the/status/1990117088837464263
71. https://www.instagram.com/reel/DPGOgieiCtW/?igsh=NzgyYTk0Y2YyNg%3D%3D
72. RFK Jr. Senate Finance Committee hearing. https://www.rev.com/transcripts/rfk-jr-senate-finance-committee-hearing
73. HHS winds down mRNA vaccine development under BARDA. HHS, Aug. 5, 2025.

🖨️ Print post